全文获取类型
收费全文 | 14410篇 |
免费 | 1159篇 |
国内免费 | 419篇 |
专业分类
耳鼻咽喉 | 27篇 |
儿科学 | 322篇 |
妇产科学 | 152篇 |
基础医学 | 980篇 |
口腔科学 | 32篇 |
临床医学 | 1816篇 |
内科学 | 4154篇 |
皮肤病学 | 37篇 |
神经病学 | 533篇 |
特种医学 | 1715篇 |
外国民族医学 | 5篇 |
外科学 | 1819篇 |
综合类 | 1947篇 |
预防医学 | 333篇 |
眼科学 | 79篇 |
药学 | 1005篇 |
9篇 | |
中国医学 | 231篇 |
肿瘤学 | 792篇 |
出版年
2024年 | 30篇 |
2023年 | 288篇 |
2022年 | 564篇 |
2021年 | 688篇 |
2020年 | 645篇 |
2019年 | 635篇 |
2018年 | 659篇 |
2017年 | 571篇 |
2016年 | 538篇 |
2015年 | 608篇 |
2014年 | 981篇 |
2013年 | 1115篇 |
2012年 | 752篇 |
2011年 | 818篇 |
2010年 | 634篇 |
2009年 | 715篇 |
2008年 | 616篇 |
2007年 | 688篇 |
2006年 | 578篇 |
2005年 | 489篇 |
2004年 | 383篇 |
2003年 | 349篇 |
2002年 | 290篇 |
2001年 | 273篇 |
2000年 | 206篇 |
1999年 | 175篇 |
1998年 | 176篇 |
1997年 | 142篇 |
1996年 | 146篇 |
1995年 | 139篇 |
1994年 | 149篇 |
1993年 | 107篇 |
1992年 | 98篇 |
1991年 | 84篇 |
1990年 | 70篇 |
1989年 | 63篇 |
1988年 | 48篇 |
1987年 | 51篇 |
1986年 | 53篇 |
1985年 | 66篇 |
1984年 | 57篇 |
1983年 | 25篇 |
1982年 | 46篇 |
1981年 | 37篇 |
1980年 | 36篇 |
1979年 | 25篇 |
1978年 | 22篇 |
1977年 | 18篇 |
1976年 | 13篇 |
1974年 | 8篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
21.
Anand Dayama Nikolaos Tsilimparis Stephen Kolakowski Nathaniel M. Matolo Misty D. Humphries 《Journal of vascular surgery》2019,69(1):156-163.e1
Background
Chronic limb-threatening ischemia (CLTI), defined as ischemic rest pain or tissue loss secondary to arterial insufficiency, is caused by multilevel arterial disease with frequent, severe infrageniculate disease. The rise in CLTI is in part the result of increasing worldwide prevalence of diabetes, renal insufficiency, and advanced aging of the population. The aim of this study was to compare a bypass-first with an endovascular-first revascularization strategy in patients with CLTI due to infrageniculate arterial disease.Methods
We reviewed the American College of Surgeons National Surgical Quality Improvement Program targeted lower extremity revascularization database from 2012 to 2015 to identify patients with CLTI and isolated infrageniculate arterial disease who underwent primary infrageniculate bypass or endovascular intervention. We excluded patients with a history of ipsilateral revascularization and proximal interventions. The end points were major adverse limb event (MALE), major adverse cardiovascular event (MACE), amputation at 30 days, reintervention, patency, and mortality. Multivariable logistic regression was used to determine the association of a bypass-first or an endovascular-first intervention with outcomes.Results
There were 1355 CLTI patients undergoing first-time revascularization to the infrageniculate arteries (821 endovascular-first revascularizations and 534 bypass-first revascularizations) identified. There was no significant difference in adjusted rate of 30-day MALE in the bypass-first vs endovascular-first revascularization cohort (9% vs 11.2%; odds ratio [OR], 0.73; 95% confidence interval [CI], 0.50-1.08). However, the incidence of transtibial or proximal amputation was lower in the bypass-first cohort (4.3% vs 7.4%; OR, 0.60; CI, 0.36-0.98). Patients with bypass-first revascularization had higher wound complication rates (9.7% vs 3.7%; OR, 2.75; CI, 1.71-4.42) compared with patients in the endovascular-first cohort. Compared with the endovascular-first cohort, the incidence of 30-day MACE was significantly higher in bypass-first patients (6.9% vs 2.6%; adjusted OR, 3.88; CI, 2.18-6.88), and 30-day mortality rates were 3.23% vs 1.8% (adjusted OR, 2.77; CI, 1.26-6.11). There was no difference in 30-day untreated loss of patency, reintervention of treated arterial segment, readmissions, and reoperations between the two cohorts. In subgroup analysis after exclusion of dialysis patients, there was also no significant difference in MALE or amputation between the bypass-first and endovascular-first cohorts.Conclusions
CLTI patients with isolated infrageniculate arterial disease treated by a bypass-first approach have a significantly lower 30-day amputation. However, this benefit was not observed when dialysis patients were excluded. The bypass-first cohort had a higher incidence of MACE compared with an endovascular-first strategy. These results reaffirm the need for randomized controlled trials, such as the Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL-2) trial and Best Endovascular vs Best Surgical Therapy in Patients with Critical Limb Ischemia (BEST-CLI), to provide level 1 evidence for the role of endovascular-first vs bypass-first revascularization strategies in the treatment of this population of challenging patients. 相似文献22.
目的探析经鼻高流量湿化氧疗用于小儿先心病术后治疗中的效果以及护理措施。方法2014年9月—2017年10月在郑州儿童医院外科监护室接受手术治疗的先心病患儿中随机抽取130例,根据术后氧疗方法不同分组:对照组患儿术后给予常规面罩吸氧,观察组患儿术后给予经鼻高流量湿化氧疗,2组患儿均给予优质术后护理,对比2组的血气指标、住院时间等。结果2组患者氧疗后24h、48h的血氧饱和度差异无统计学意义,在氧疗后24h的PaCO2水平差异无统计学意义,而在氧疗后24h和48h的氧合指数,观察组明显高于对照组,差异有统计学意义(P<0.05);2组ICU入住时间和总住院时间差异无统计学意义(P>0.05)。结论经鼻高流量湿化氧疗的应用提高先心病患儿术后的舒适度,改善呼吸状况,值得推广。 相似文献
23.
Gary E. Stapleton Benjamin W. Eidem Ricardo H. Pignatelli Karina M. Carlson Charles E. Mullins Ronald G. Grifka 《Congenital heart disease》2006,1(3):116-119
Background. A persistent patent ductus arteriosus (PDA) may delay closure of a coexisting atrial septal defect (ASD) due to volume loading and enlargement of the left atrium. The purpose of this study was to investigate the natural history of ASD size in patients with a PDA following transcatheter PDA occlusion. Methods. All patients with an ASD and a PDA who underwent transcatheter PDA occlusion at Texas Children’s Hospital were identified. Patients with ASD diameter <3 mm, or additional cardiac defects were excluded. Eight patients (7 females) with small‐ to moderate‐sized ASDs and a PDA were identified. Patient demographics, echocardiographic data, and cardiac catheterization data were recorded. Data were analyzed by 1‐tailed t‐test. Results. Following PDA occlusion, ASD diameter decreased in 6 of 8 patients by a mean of 3.8 mm (±2.3 mm), including 2 that closed. The median duration of follow‐up was 689 days. One ASD remained unchanged and 1 increased in size. The mean maximum ASD diameter decreased from 6.4 mm (±2.2 mm) to 3.9 mm (±3.4 mm) (P = .03). Two patients underwent subsequent transcatheter ASD occlusion. Conclusion. Following transcatheter PDA occlusion, small‐ to moderate‐sized ASDs have significant probability to decrease in size, and possibly close. In infants and children, we recommend transcatheter PDA occlusion, and serial follow‐up of the size of the ASD. This will allow many small‐ to moderate‐sized ASDs to either close, or become smaller, obviating the need for future intervention. 相似文献
24.
25.
Joachim Dissemond Andreas Krber Stephan Grabbe 《Journal der Deutschen Dermatologischen Gesellschaft》2006,4(8):627-634
In Germany about 0.7 % of the adult population have a chronic leg ulcer. Although chronic venous insufficiency accounts for at least 80 % of all chronic leg ulcers, knowledge of the relevant differential diagnostic considerations is of crucial importance, in particular for patients who are refractory to therapy. In addition to vascular disease, other causes include neuropathic, metabolic, hematologic and exogenous factors as well as neoplasias, infections, drugs, genetic defects and some primary skin disorders. For the long‐term successful treatment of patients with chronic leg ulcers, it is necessary to identify all relevant factors, in order to enable a pathogenesis‐oriented, interdisciplinary therapeutic approach. 相似文献
26.
粉防己碱对野百合碱致大鼠肺动脉构形重建的逆转作用 总被引:2,自引:0,他引:2
以野百合碱复制Wistar大鼠肺动脉高压模型,用特殊染色方法观察粉防已碱对野百合碱致大鼠肺动脉构形重建的逆转作用,结果表明粉防已碱可选择性的降低野百合碱诱导的大鼠肺动脉高压的作用,并明显地逆转肺血管及肺组织损伤,降低肺动脉高压和右心室肥大,对体循环压力无影响 相似文献
27.
G. V. Petrova V. A. Adarichev A. A. Krivenko G. S. Dymshits A. L. Markel' G. S. Yakobson 《Bulletin of experimental biology and medicine》1997,124(2):773-775
Sensitivity of normotensive Wistar rats and NISAG rats (with hereditary arterial hypertension) to heat stress is compared
at the organism and cell levels. High temperature sensitivity of NISAG rats correlates with a low content of the main heat
shock protein HSP70. This relationship can serve as a biochemical marker of predisposition to arterial hypertension.
Translated fromByulleten' Eksperimental'noi Biologii i Meditsiny, Vol. 124, No. 8, pp. 171–173, August, 1997 相似文献
28.
顺铂聚乳酸微球的药物释放特性及肝动脉栓塞研究 总被引:5,自引:0,他引:5
对顺铂聚乳酸微球进行了体外药物释放和家犬肝动脉栓塞研究。该微球粒径范围为50~200μm,平均粒径为115.76±35.94μm,顺铂含量为37.16%(W/W);体外药物释放机制符合Higuchi方程;肝动脉栓塞后8h,肝组织顺铂浓度高达21.55±12.18μg/g,明显高于肝动脉灌注顺铂组:3.16±0.09μg/g(P<0.05);肝动脉栓塞组的顺铂血浓峰值、各取血点浓度及曲线下面积AUC皆低于肝动脉灌注顺铂组。可望达到提高栓塞部位的药物疗效,降低全身毒副反应的作用。 相似文献
29.
目的总结和探讨脑血管造影和载瘤动脉闭塞在治疗颅内巨大动脉瘤上的作用及特点。方法60例颅内巨大动脉瘤患者,根据其脑血管造影的特点采取血管内介入方法[可脱式球囊和(或)弹簧圈]闭塞载瘤动脉近端53例、闭塞载瘤动脉两端后孤立动脉瘤7例;其中23例闭塞前先行颅内-外血管搭桥术。结果出院时Rankin评分分级:单纯血管内介入治疗组37例中轻残3例,合并颅内-外血管搭桥术组23例中死亡1例、重残2例。1-6年的影像学随访动脉瘤无复发。结论血管内介入结合颅内-外血管搭桥术闭塞载瘤动脉是治疗颅内巨大动脉瘤的方法之一。 相似文献
30.